Xerys Invest
Xerys Invest is a French private equity firm founded in 2009, specializing in supporting entrepreneurs and management teams at all stages of growth, from venture capital to maturity, with a focus on sustainable value creation. The firm manages over 200 million euros in assets and invests mainly in healthcare, life sciences, renewable energy, and greentech sectors.
Xerys Invest is a PARIS venture capital firm with €389M AUM, 6 active companies and 4 exits.
- ·3 exits in the last 5 years · consistent DPI cadence.
- ·Average hold across 4 realized deals: 6 years.
- ·Top sector focus: TMT (30% of portfolio).
Sector breakdown
10 companiesKey facts
Recent exits
Xerys Invest sold Optionizr to SoftNext in 2025 after 7 years.
Xerys Invest sold Cryo Pur to Francaise de l'Energie in 2022 after 7 years.
Xerys Invest exited Herow in 2022 after 7 years.
Xerys Invest sold 7Hugs Labs to Qorvo in 2020 after 3 years.
Coverage notes
1 fund tracked, 10 portfolio companies (6 active · 4 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Xerys Invest has raised, with its portfolio companies. Hand-checked from public filings.
Xerys Capital FranceGrowth2014€100M6 assets4 exitsGrowth2014 · 12yr€100M64
Unrealized
6 held| Company | Entry |
|---|---|
| Advanced BioDesign Biotech · France | 2016 |
| AlzProtect Biotech · France | 2017 |
| Biolog-id MedTech · France | 2022 |
| Powidian ClimateTech · France | 2016 |
| PowiDian Mobility / LMI France | 2021 |
| Skytech TMT · France | 2013 |
Realized
4 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| 7Hugs Labs Software · France | 2017 | 2020 | Trade Sale | Qorvo | – |
| Cryo Pur Healthcare · France | 2015 | 2022 | Trade Sale | Francaise de l'Energie | – |
| Herow TMT · France | 2015 | 2022 | – | – | – |
| Optionizr TMT · France | 2018 | 2025 | Trade Sale | SoftNext | – |
About Xerys Invest
Xerys Invest is a French private equity firm with €200 million of assets under management, founded in 2009 and headquartered in Paris. The firm specialises in supporting entrepreneurs and management teams at all stages of growth, from venture capital to maturity, with a focus on sustainable value creation across multi-stage investment vehicles.
Investment thesis
Xerys Invest targets French and selectively European companies across the company lifecycle, deploying venture capital (early-stage), growth equity (scaling) and selective buyout positions with the multi-stage mandate enabling flexibility across distinct return profiles. Sector focus spans the broad coverage typical of multi-strategy platforms, with the firm emphasising operational partnership with founder-operator management teams across the holding period.
Recent activity
Recent realised exits include Cryo Pur (healthcare, 2022), reflecting selective distribution activity. The platform tracks a single dedicated fund vehicle, 4 active portfolio companies and 4 realised exits across the multi-stage French programme.
Frequently asked questions
- What investment strategy does Xerys Invest focus on?
- Xerys Invest focuses on VC, Growth, Buyout strategies in the private equity space.
- How many portfolio companies does Xerys Invest have?
- Xerys Invest has 6 active portfolio companies and 4 completed exits and 1 fund tracked on GP Intel.
- Where is Xerys Invest headquartered?
- Xerys Invest is headquartered in PARIS, France.
- What is Xerys Invest's assets under management?
- Xerys Invest manages approximately €389M in assets under management.
- When was Xerys Invest founded?
- Xerys Invest was founded in 2013.
- What sectors does Xerys Invest invest in?
- Xerys Invest invests across Healthcare, Energy, TMT, Industrials.
- What are Xerys Invest's recent exits?
- Recent realized exits by Xerys Invest include: Optionizr (2025) to SoftNext; Cryo Pur (2022) to Francaise de l'Energie; 7Hugs Labs (2020) to Qorvo.
Similar firms
Other private equity firms tracked on GP Intel.